Yes I thought there was phase 3 trial going on from the annual report - but HT seems to, as usual, scoff at any positive notion regarding QIN, citing what appears to be evidence from 2014 - I could be wrong of course.
Ah well mid 2018 is not too far away and perhaps the matter will be revealed in the upcoming info releases form the coy.
- Forums
- ASX - By Stock
- QIN
- Santalis FDA phase 2 details
Santalis FDA phase 2 details, page-5
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online